These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 27510740)
21. Mind the gap: Physicians' assessment of patients' importance weights in localized prostate cancer. Tentori K; Pighin S; Divan C; Crupi V PLoS One; 2018; 13(7):e0200780. PubMed ID: 30048485 [TBL] [Abstract][Full Text] [Related]
22. Association of Actual and Preferred Decision Roles With Patient-Reported Quality of Care: Shared Decision Making in Cancer Care. Kehl KL; Landrum MB; Arora NK; Ganz PA; van Ryn M; Mack JW; Keating NL JAMA Oncol; 2015 Apr; 1(1):50-8. PubMed ID: 26182303 [TBL] [Abstract][Full Text] [Related]
23. Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer. Kim SP; Gross CP; Nguyen PL; Smaldone MC; Thompson RH; Shah ND; Kutikov A; Han LC; Karnes RJ; Ziegenfuss JY; Tilburt JC Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):163-9. PubMed ID: 24566445 [TBL] [Abstract][Full Text] [Related]
24. Impact of health information-seeking behavior and personal factors on preferred role in treatment decision making in men with newly diagnosed prostate cancer. Davison BJ; Breckon EN Cancer Nurs; 2012; 35(6):411-8. PubMed ID: 22067700 [TBL] [Abstract][Full Text] [Related]
25. Urologists' personal feelings on PSA screening and prostate cancer treatment. Wenzler DL; Rosenberg BH J Eval Clin Pract; 2014 Aug; 20(4):408-10. PubMed ID: 24798149 [TBL] [Abstract][Full Text] [Related]
26. Factors which motivate cancer doctors to involve their patients in reaching treatment decisions. Shepherd HL; Butow PN; Tattersall MH Patient Educ Couns; 2011 Aug; 84(2):229-35. PubMed ID: 21112174 [TBL] [Abstract][Full Text] [Related]
27. Impact of genomic testing on urologists' treatment preference in favorable risk prostate cancer: A randomized trial. Carbunaru S; Sun Z; McCall C; Ofori B; Marshall N; Wang H; Abern M; Liu L; Hollowell CMP; Sharifi R; Vidal P; Kajdacsy-Balla A; Sekosan M; Ferrer K; Wu S; Gallegos M; Gann PH; Moreira D; Sharp LK; Ferrans CE; Murphy AB Cancer Med; 2023 Oct; 12(19):19690-19700. PubMed ID: 37787097 [TBL] [Abstract][Full Text] [Related]
28. How Men with Prostate Cancer Choose Specialists: A Qualitative Study. Jiang T; Stillson CH; Pollack CE; Crossette L; Ross M; Radhakrishnan A; Grande D J Am Board Fam Med; 2017; 30(2):220-229. PubMed ID: 28379829 [TBL] [Abstract][Full Text] [Related]
29. Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer. Davison BJ; Goldenberg SL BJU Int; 2011 Dec; 108(11):1787-93. PubMed ID: 21507187 [TBL] [Abstract][Full Text] [Related]
30. [Shared decision-making in prostate cancer patients]. Gröger S; Mäder-Porombka C; Stang C; Wallacher S Urologe A; 2019 Nov; 58(11):1324-1330. PubMed ID: 30238132 [TBL] [Abstract][Full Text] [Related]
31. How older patients' treatment preferences are influenced by disclosures about therapeutic uncertainty: surgery versus expectant management for localized prostate cancer. Mazur DJ; Merz JF J Am Geriatr Soc; 1996 Aug; 44(8):934-7. PubMed ID: 8708303 [TBL] [Abstract][Full Text] [Related]
32. Patient treatment preferences in localized prostate carcinoma: The influence of emotion, misconception, and anecdote. Denberg TD; Melhado TV; Steiner JF Cancer; 2006 Aug; 107(3):620-30. PubMed ID: 16802287 [TBL] [Abstract][Full Text] [Related]
33. Not asking cancer patients about their preferences does make a difference. A cross-sectional study examining cancer patients' preferred and perceived role in decision-making regarding their last important cancer treatment. Herrmann A; Hall A; Sanson-Fisher R; Zdenkowski N; Watson R; Turon H Eur J Cancer Care (Engl); 2018 Sep; 27(5):e12871. PubMed ID: 29900611 [TBL] [Abstract][Full Text] [Related]
34. Shared decision making about palliative chemotherapy: A qualitative observation of talk about patients' preferences. Henselmans I; Van Laarhoven HW; Van der Vloodt J; De Haes HC; Smets EM Palliat Med; 2017 Jul; 31(7):625-633. PubMed ID: 28618897 [TBL] [Abstract][Full Text] [Related]
35. Veterans' decision-making preferences and perceived involvement in care for chronic heart failure. Rodriguez KL; Appelt CJ; Switzer GE; Sonel AF; Arnold RM Heart Lung; 2008; 37(6):440-8. PubMed ID: 18992627 [TBL] [Abstract][Full Text] [Related]
36. Prostate cancer survivors with a passive role preference in treatment decision-making are less satisfied with information received: Results from the PROFILES registry. Cuypers M; Lamers RED; de Vries M; Husson O; Kil PJM; van de Poll-Franse LV Urol Oncol; 2016 Nov; 34(11):482.e11-482.e18. PubMed ID: 27432432 [TBL] [Abstract][Full Text] [Related]
37. Current decision-making in prostate cancer therapy. Cox J; Amling CL Curr Opin Urol; 2008 May; 18(3):275-8. PubMed ID: 18382237 [TBL] [Abstract][Full Text] [Related]
38. Association of reimbursement policy and urologists' characteristics with the use of medical androgen deprivation therapy for clinically localized prostate cancer. Quek RG; Master VA; Portier KM; Ward KC; Lin CC; Virgo KS; Lipscomb J Urol Oncol; 2014 Aug; 32(6):748-60. PubMed ID: 24840868 [TBL] [Abstract][Full Text] [Related]
39. Integrating Patient Preference into Treatment Decisions for Men with Prostate Cancer at the Point of Care. Johnson DC; Mueller DE; Deal AM; Dunn MW; Smith AB; Woods ME; Wallen EM; Pruthi RS; Nielsen ME J Urol; 2016 Dec; 196(6):1640-1644. PubMed ID: 27346032 [TBL] [Abstract][Full Text] [Related]
40. Prostate Cancer Patients' Understanding of the Gleason Scoring System: Implications for Shared Decision-Making. Tagai EK; Miller SM; Kutikov A; Diefenbach MA; Gor RA; Al-Saleem T; Chen DYT; Fleszar S; Roy G J Cancer Educ; 2019 Jun; 34(3):441-445. PubMed ID: 29333577 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]